Long-Acting Beta-Agonists Market to Reach USD 18 Billion by 2035 Driven by Rising Respiratory Cases
The Long-Acting Beta-Agonists Market is on track for significant expansion, projected to grow from USD 8.8 billion in 2025 to an impressive USD 18.0 billion by 2035, registering a robust compound annual growth rate (CAGR) of 7.4%. This growth reflects the rising global burden of respiratory diseases, continuous innovations in drug formulations, and strong market performanceRead More










